Cargando…
Hidden GBV: Women and substance use
Gender based violence (GBV) is disproportionately higher in women who use substances. This vulnerable population are also at a disadvantage when it comes to accessing harm reduction services. Between May and October 2021 there were 77 cases discussed at Multi-Agency Risk Assessment Conferences (MARA...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393579/ https://www.ncbi.nlm.nih.gov/pubmed/36003973 http://dx.doi.org/10.3389/fpsyt.2022.939105 |
_version_ | 1784771300710940672 |
---|---|
author | Moir, Eilidh Gwyther, Sophie Wilkins, Heather Boland, Gillian |
author_facet | Moir, Eilidh Gwyther, Sophie Wilkins, Heather Boland, Gillian |
author_sort | Moir, Eilidh |
collection | PubMed |
description | Gender based violence (GBV) is disproportionately higher in women who use substances. This vulnerable population are also at a disadvantage when it comes to accessing harm reduction services. Between May and October 2021 there were 77 cases discussed at Multi-Agency Risk Assessment Conferences (MARAC) in Dundee. The majority of these cases (62) had substance misuse as a risk factor. It is at these meetings that the vulnerability of women comes to the fore and issues of violence are highlighted. During this time period, 44 cases involved the victim being strangled/choked or suffocated and 43 cases had weapons as a risk factor. 56 of the cases included children. The issue of GBV or Intimate Partner Violence (IPV) is often hidden, especially in and by those affected by substance use. Women experiencing GBV require specialist support, often across different services to address different needs. How well violence against women is understood in relationships that are affected by drugs is difficult to determine. In many instances it isn't until a MARAC meeting, or similar crisis point is met, that the extent of the abuse is highlighted. What services can provide singularly is limited in many of these cases but joint-working and innovative practices, such as the Hub model and the Gendered Services Project in Dundee, strive to change the landscape of service delivery. |
format | Online Article Text |
id | pubmed-9393579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93935792022-08-23 Hidden GBV: Women and substance use Moir, Eilidh Gwyther, Sophie Wilkins, Heather Boland, Gillian Front Psychiatry Psychiatry Gender based violence (GBV) is disproportionately higher in women who use substances. This vulnerable population are also at a disadvantage when it comes to accessing harm reduction services. Between May and October 2021 there were 77 cases discussed at Multi-Agency Risk Assessment Conferences (MARAC) in Dundee. The majority of these cases (62) had substance misuse as a risk factor. It is at these meetings that the vulnerability of women comes to the fore and issues of violence are highlighted. During this time period, 44 cases involved the victim being strangled/choked or suffocated and 43 cases had weapons as a risk factor. 56 of the cases included children. The issue of GBV or Intimate Partner Violence (IPV) is often hidden, especially in and by those affected by substance use. Women experiencing GBV require specialist support, often across different services to address different needs. How well violence against women is understood in relationships that are affected by drugs is difficult to determine. In many instances it isn't until a MARAC meeting, or similar crisis point is met, that the extent of the abuse is highlighted. What services can provide singularly is limited in many of these cases but joint-working and innovative practices, such as the Hub model and the Gendered Services Project in Dundee, strive to change the landscape of service delivery. Frontiers Media S.A. 2022-08-08 /pmc/articles/PMC9393579/ /pubmed/36003973 http://dx.doi.org/10.3389/fpsyt.2022.939105 Text en Copyright © 2022 Moir, Gwyther, Wilkins and Boland. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Moir, Eilidh Gwyther, Sophie Wilkins, Heather Boland, Gillian Hidden GBV: Women and substance use |
title | Hidden GBV: Women and substance use |
title_full | Hidden GBV: Women and substance use |
title_fullStr | Hidden GBV: Women and substance use |
title_full_unstemmed | Hidden GBV: Women and substance use |
title_short | Hidden GBV: Women and substance use |
title_sort | hidden gbv: women and substance use |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393579/ https://www.ncbi.nlm.nih.gov/pubmed/36003973 http://dx.doi.org/10.3389/fpsyt.2022.939105 |
work_keys_str_mv | AT moireilidh hiddengbvwomenandsubstanceuse AT gwythersophie hiddengbvwomenandsubstanceuse AT wilkinsheather hiddengbvwomenandsubstanceuse AT bolandgillian hiddengbvwomenandsubstanceuse |